vimarsana.com

Page 88 - தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Berger to Construct DPR s 10 Storey new Headquarters Building

By Bennett Oghifo Julius Berger Nigeria Plc, has been chosen to construct the new headquarters building of the Department of Petroleum Resources (DPR). Located at the strategic Central Business District of the Federal Capital Territory Abuja, the iconic 10-storey building design also called “The Barrel”, is a challenging foretaste in magnitude and technical standard. But Julius Berger says it is a welcome challenge. Speaking at the event in Abuja, the Managing Director of Julius Berger, Engr. Dr. Lars richter, a well-recognised consummate engineering practitioner who, amongst other professional qualifications, holds a doctorate degree in civil engineering, said: “The building itself reflects an outstanding barrel design, drawing inspiration from the physical oil barrel itself. It is a modern office building, thoughtfully designed to include and balance the requirements of today’s contemporary work environments”. The building, he further said “features

Curve Names CreditEase Investment Leader and Former Citi and Standard Chartered Chief Anju Patwardhan as Non-executive Director

(2) Banker turned fintech investor bolsters Curve Board, ahead of expansion into US, deeper push into Europe and launch of Curve Credit Curve, the London-based fintech that combines multiple cards and accounts into one smart card and even smarter app, has named Anju Patwardhan as a non-executive director to the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005705/en/ Curve names former Citi and Standard Chartered chief Anju Patwardhan as non-executive director (Photo: Business Wire) Anju brings decades of expertise and leadership in financial services and innovation to Curve. She was most recently managing partner at CreditEase Fintech VC Fund, one of China s largest fintech venture funds. CreditEase focuses on wealth management and inclusive finance in China, and Anju remains an advisor there.

Investegate |Giesecke + Devrient GmbH Announcements | Giesecke + Devrient GmbH: Giesecke+Devrient decides to sell a 3 85% stake in secunet Security Networks AG via Accelerated Bookbuilding to increase free float

A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;

iBiopsy®: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego)

Press release content from Business Wire. The AP news staff was not involved in its creation. iBiopsy®: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego) February 9, 2021 GMT Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA) announces today the company has signed a research collaboration agreement with the University of California San Diego (UC San Diego) aimed at carrying out a study that will be used for its proprietary imaging platform iBiopsy® validation. The study is related to the iBiopsy® NASH Clinical Development Plan (CDP). It is estimated that NASH is affecting 1.5-6.45 % of the global population 1.

iBiopsy: Median Technologies Inks a Major Research Collaboration Agreement With the University of California San Diego (UC San Diego)

(1) The research collaboration agreement covers a joint clinical retrospective study on liver fibrosis severity in Non-Alcoholic Steato-Hepatitis (NASH) patients The collaboration will enable Median to work on a large NASH patient cohort to lead the validation of its iBiopsy s AI technology, applied to liver fibrosis characterization The Liver Center at UC San Diego is a world-renowned university and healthcare center for liver diseases, with a focus on Non-Alcoholic Fatty Liver Disease (NAFLD) NASH Regulatory News: Median Technologies (Paris:ALMDT) (ALMDT:PA) announces today the company has signed a research collaboration agreement with the University of California San Diego (UC San Diego) aimed at carrying out a study that will be used for its proprietary imaging platform iBiopsy validation. The study is related to the iBiopsy NASH Clinical Development Plan (CDP).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.